Beste HNO-Ärzte - TOP-464 Ärzte

Der Arzt hat das Medizinstudium in der Türkei abgeschlossen, an einem Kurs zum Sezieren des Schläfenbeins, einem Rehabilitationskurs bei Patienten mit Laryngektomie und Praktika in der Hals-Nasen-Ohrenheilkunde und allgemeinen Chirurgie in Deutschland teilgenommen. Darüber hinaus war der Mediziner sowohl in der Türkei als auch in Deutschland als Allgemeinmediziner und HNO-Arzt tätig.

Op.Dr. İbrahim Altoparlak was born in 1977 in Erzurum.

He started his medical education at Ankara University Faculty of Medicine in 1995 and completed it in 2001. In 2001, he started his specialization training at Ankara University Faculty of Medicine, Ear Nose and Throat Clinic, and completed his specialization in 2006. Between 2006 and 2009, he improved himself in Head and Neck Tumor Surgery and Aesthetic Nose Operations in Ankara Oncology Hospital, Ear Nose and Throat Training Clinic. He has awarded papers at scientific meetings and articles published in scientific journals. Between 2010 and 2018, he worked as a physician at Istanbul Private Doğan Hospital and Private Service Hospital. He has been working in his own practice as of October 2018. In addition, since 2021, 

Dr.Altoparlak continues his operations with the Aesthepan clinic. Dr.Altoparlak performs at least 2 or 3 aesthetic operations a day, and he has hundreds of successful surgeries.

Any other educational courses and certificate (those conducted internationally as well):

1. Otorhinolaryngology Allergy Course 2004

2. Occupational English Test OET certificate 2016

3. Ege university Cadaver DBsection Course 2017

Memberships & Associations (Please list all your local, regional and international memberships

Dr. Turgay Toğçuoğlu, with 20 years of experience, has performed many successful surgeries in the field of otolaryngology. He has performed many surgeries on Rhinoplasty

Biography

Dr. Mehdi Afrit is a Medical Oncologist who practices at Burjeel Specialty Hospital in Sharjah. He has over 11 years of experience caring for and managing cancer patients. He has extensive experience providing chemotherapy, hormonal therapy, immunotherapy, and targeted therapy to patients. He earned a Certificate of Medical Oncology from the Gustave Roussy Institute in Paris, France, where he received training in antitumor chemotherapy and cancer medical treatment. Additionally, he holds an international certificate in breast diseases. He also has a certificate in Good Clinical Practice from Trans Celerate Biopharma Inc. and a certificate in Clinical Trial Management: Good Clinical Practice from the Faculty of Pharmaceutical Medicine of the Royal College of Physicians. He previously worked for over five years as an Assistant Professor of Medical Oncology at Tunis’s Faculty of Medicine. He later practiced as a Consultant, Medical Oncologist for six years at Arianna’s hospital in Tunisia. He later worked for two years as a Specialist Medical Oncologist at Zulekha Hospital. He was also an investigator in three international clinical trials and holds clinical trial auditing and CRO certifications and a GCP Training Certificate from 2016. He is a member in good standing of the Emirates Oncology Society (EOS), the European Society of Medical Oncology (ESMO), and the American Society of Clinical Oncology (ASCO). His clinical expertise includes but is not limited to the following:

• Oncology care and treatment for chemotherapy, hormonal therapy, immune therapy, and target therapy
• Breast cancer
• Solid tumor diagnosis
• Digestive cancer
• Gynecological cancer
• Lung cancer
• Genitourinary cancer
• Sarcoma

Awards & Achievements

• Award from Himaya Foundations and University of Sharjah

Research & Publications

• Clinicopathological Features of Gastric Cancer in a Cohort of Gulf Council Countries' Patients: A Cross-Sectional Study of 96 Cases. Journal of Oncology Research Reviews & Reports Volume 2(2): 1-3.
• The Burden of Gynecologic Cancers in the UAE. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The Emirates Oncology Task Force Clinical Practice Guideline on Screening for SARS-CoV-2 in Asymptomatic Adult Cancer Patients Before Anti-Cancer Therapy. Journal of Oncology Research Reviews & Reports Volume 2(4): 1-6.
• The State of Cancer Care in the United Arab Emirates in 2020: Challenges and Recommendations, A report by the United Arab Emirates Oncology Task Force. Humaid Al-Shamsi, Humaa Darr, Ibrahim Abu-Gheida , Jawaher Ansari, Martine, Mehdi Afrit, Mohamad H Masri, Mohamed Abuhaleeqa. Gulf J Oncology 2020 Jan;1(32):71-87.
• Primary Bone Lymphoma: Tunisian Multicentric Retrospective Study About 32 Cases. Ben Ayed C, Laabidi S, Said N, Afrit M, Ben Ahmed S, Boussen H. Tunis Med. 2018 May;96(5):269-272.
• First Site of Recurrence After Breast Cancer Adjuvant Treatment in the Era of Multimodality Therapy: Which Imaging for Which Patient During Follow-up? Nesrine M, Mehdi B, Houda EB, Soumaya L, Mehdi A, Bechir Z, Hamouda B. Breast Dis. 2017 Nov 21